Displaying drugs 651 - 675 of 2796 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Altretamine | 210.2794 C9H18N6 |  | An antineoplastic agent used in palliative treatment of persistent or recurrent ovarian cancer. | Antineoplastic Agents |
| Nicorandil | 211.177 C8H9N3O4 |  | A vasodilatory drug that functions through potassium channels and intracellular cGMP concentrations commonly used to treat angina. | Antiarrhythmic agents / Antihypertensive Agents / Nitrates / Vasodilating Agents |
| Methyldopa | 211.2145 C10H13NO4 |  | A centrally-acting alpha-2 adrenergic agonist used to manage hypertension alone or in combination with hydrochlorothiazide, and to treat hypertensive crises. | Adrenergic alpha-2 Receptor Agonists / Antihypertensive Agents Indicated for Hypertension / Central alpha-2 Adrenergic Agonist / Dihydroxyphenylalanine / Sympatholytics |
| Zalcitabine | 211.2178 C9H13N3O3 |  | A dideoxynucleoside used to treat HIV. | Nucleoside and Nucleotide Reverse Transcriptase Inhibitors |
| Milrinone | 211.2194 C12H9N3O |  | A PDE-III inhibitor with inotropic, lusitropic, and vasodilatory properties used for the short-term treatment of acute decompensated heart failure. | Cardiotonic Agents / Phosphodiesterase 3 Inhibitors / Phosphodiesterase Inhibitors / Vasodilating Agents |
| Isoprenaline | 211.2576 C11H17NO3 |  | A catecholamine non-selective beta-adrenergic agonist typically used to treat bradycardia and heart block. | Adrenergic and Dopaminergic Agents |
| Orciprenaline | 211.2576 C11H17NO3 |  | A beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD. | Non-selective Beta-adrenergic Agonists |
| Methoxamine | 211.2576 C11H17NO3 |  | An alpha adrenergic agonist used to treat hypotension. | Adrenergic and Dopaminergic Agents |
| Diphenylguanidine | 211.268 C13H13N3 |  | Diphenylguanidine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years... | Standardized Chemical Allergen |
| Varenicline | 211.268 C13H13N3 |  | A partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation. | Drugs Used in Nicotine Dependence |
| Pramipexole | 211.327 C10H17N3S |  | A non-ergot dopamine agonist used to treat the signs and symptoms of idiopathic Parkinson's disease and Restless Legs Syndrome (RLS). | Anti-Parkinson Drugs / Dopamine Agents |
| Zonisamide | 212.226 C8H8N2O3S |  | A sulfonamide anticonvulsant used to treat partial seizures. | Sulfonamides |
| Benzoin | 212.2439 C14H12O2 |  | No approved therapeutic indications. | Acetophenones |
| Benzyl benzoate | 212.2439 C14H12O2 |  | A topical treatment for scabies and lice. | Insecticides |
| Butobarbital | 212.2456 C10H16N2O3 |  | For the treatment of insomnia. | Barbiturates, Plain |
| Butabarbital | 212.2456 C10H16N2O3 |  | A barbiturate drug used as a sedative and hypnotic. | Anticholinergic Agents / Anticonvulsants / Barbiturates / Central Nervous System Agents / Central Nervous System Depressants / Drugs that are Mainly Renally Excreted / Hypnotics and Sedatives / Nervous System / Nicotinic Antagonists / Psycholeptics / Pyrimidines / Pyrimidinones |
| Brivaracetam | 212.2887 C11H20N2O2 |  | An anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain. | Anticonvulsants / Central Nervous System Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Epoxide Hydrolase Inhibitors / Miscellaneous Anticonvulsants / Nervous System / Pyrrolidines |
| Droxidopa | 213.189 C9H11NO5 |  | A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease. | Adrenergic and Dopaminergic Agents |
| Salicylanilide | 213.236 C13H11NO2 |  | Not Annotated | Amides / Amines / Anilides / Aniline Compounds / Salicylamides |
| Phenazopyridine | 213.2385 C11H11N5 |  | A local anesthetic used for the symptomatic relief of pain, burning, urgency, frequency, and general discomfort caused by lower urinary tract irritations that are a result of infection, trauma, surgery, endoscopic procedures, or the passage of equipment or catheters. | Aminopyridines |
| Guanadrel | 213.2768 C10H19N3O2 |  | Used to treat and control hypertension. | Antihypertensive Agents |
| Baclofen | 213.661 C10H12ClNO2 |  | A GABA-ergic agonist used to manage severe spasticity of cerebral or spinal origin in adult and pediatric patients. | GABA-B Receptor Agonists / gamma-Aminobutyric Acid-ergic Agonist |
| Chloroxine | 214.048 C9H5Cl2NO |  | An antibacterial agent used for the treatment of dandruff and mild to moderately severe seborrheic dermatitis of the scalp. | Anti-Bacterial Agents / Antifungal Agents |
| Carmustine | 214.05 C5H9Cl2N3O2 |  | An alkylating agent used in the treatment of various malignancies, including brain tumours and multiple myeloma, among others. | Nitrosoureas |
| Fluorodopa (18F) | 214.183 C9H10FNO4 |  | Fluorodopa F 18 is indicated for use with positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes... | Fluorine Radioisotopes |
Displaying drugs 651 - 675 of 2796 in total